 |
|
Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
Yong-Soo Byun, Chang Rae Rho, Kyungjin Cho, Jin A Choi, Kyung Sun Na, Choun-Ki Joo
Korean J Ophthalmol. 2011;25(6):369-374. Published online 2011 Nov 22 DOI: https://doi.org/10.3341/kjo.2011.25.6.369
|
|
Citations to this article as recorded by
 Management of inflammation in dry eye disease: Recommendations from a European panel of experts
Elisabeth M Messmer, Sajjad Ahmad, José M Benitez del Castillo, Ewa Mrukwa-Kominek, Maurizio Rolando, Oksana Vitovska, Christophe Baudouin
European Journal of Ophthalmology.2023; 33(3): 1294. CrossRef A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study
Hugo Quiroz-Mercado, Everardo Hernandez-Quintela, Kuei Hsun Chiu, Eugenia Henry, Jeffrey A. Nau
The Ocular Surface.2022; 24: 15. CrossRef Different Number of Sessions of Intense Pulsed Light and Meibomian Gland Expression Combination Therapy for Meibomian Gland Dysfunction
Seung Hyeun Lee, Minjeong Kim, Won Jun Lee, Yeoun Sook Chun, Kyoung Woo Kim
Korean Journal of Ophthalmology.2022; 36(6): 527. CrossRef Association of Killer Cell Immunoglobulin-like Receptor Genotypes and Haplotypes in Dry Eye Disease Patients Treated with Restasis and Systane
Gui-Fang Ren, Lin Zhu, Yun-Long Zhuang, Yun-Xia Liu, Jing Huang, Hui Wang, Qun Wang
Ocular Immunology and Inflammation.2021; 29(5): 877. CrossRef Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review
Louis Tong, Chi Chin Sun, Kyung Chul Yoon, Ruben Lim Bon Siong, Vilavun Puangsricharern, Christophe Baudouin
Ocular Immunology and Inflammation.2021; 29(7-8): 1606. CrossRef Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
Mehmet Ozgur Cubuk, Ahmet Yucel Ucgul, Armagan Ozgur, Kemal Ozulken, Erdem Yuksel
International Ophthalmology.2021; 41(4): 1479. CrossRef Contributing Factors Affecting Ocular Discomfort on Instillation and Compliance of 0.1% Cyclosporine A Cationic Nanoemulsion
Won Jun Lee, Yeoun Sook Chun, Kyoung Woo Kim
Journal of the Korean Ophthalmological Society.2021; 62(4): 429. CrossRef Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome
Jonghwa Kim, Tae Kyu Moon, Hyeon Jeong Yoon, Yong Sok Ji, Kyung Chul Yoon
Journal of Ocular Pharmacology and Therapeutics.2021; 37(8): 472. CrossRef Effects of Eye Drops Containing Hyaluronic Acid-Nimesulide Conjugates in a Benzalkonium Chloride-Induced Experimental Dry Eye Rabbit Model
Tzu-Yang Chen, Ching-Li Tseng, Chih-An Lin, Hua-Yang Lin, Parthiban Venkatesan, Ping-Shan Lai
Pharmaceutics.2021; 13(9): 1366. CrossRef Topical Cyclosporine A 0.05% for the Treatment of Dry Eye Disease
Naeima M. Elzlitni, Samar A. Bukhatwa , Sabah S. Eldressi
Al-Mukhtar Journal of Sciences.2021; 36(1): 34. CrossRef A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
Harrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, Christian Paba, Abdullah A. Cheema, Ryan S. Kim, Anat Galor
Drugs.2020; 80(6): 547. CrossRef Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease Darrell E White, Yang Zhao, Hemalatha Jayapalan, Pattabhi Machiraju, Ramu Periyasamy, Abayomi Ogundele
Clinical Ophthalmology.2020; Volume 14: 875. CrossRef Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears Alice T Epitropoulos, Anthony Therattil, Laura M Periman, Eric D Rosenberg
Clinical Ophthalmology.2020; Volume 14: 1921. CrossRef Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren’s Syndrome Dry Eye
Min-Ji Kang, Youn-Hee Kim, Miyoung Chou, Jehyung Hwang, Eun-Jeong Cheon, Hyun-Jung Lee, So-Hyang Chung
Ocular Immunology and Inflammation.2020; 28(3): 370. CrossRef Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model
Xiang Lin, Yang Wu, Liying Tang, Weijie Ouyang, Yiran Yang, Zhaolin Liu, Jieli Wu, Xiaoxiang Zheng, Caihong Huang, Yueping Zhou, Xiaobo Zhang, Yongxiong Chen, Wei Li, Jiaoyue Hu, Zuguo Liu
Translational Vision Science & Technology.2020; 9(13): 22. CrossRef Topical Cyclosporine (0.05%) for Management of Dry Eyes in Patients Undergoing Cataract Surgery-A Comparative Study
Sri Ganesh, Sheetal Brar, Sheetal N. Bagare
The Open Ophthalmology Journal.2019; 13(1): 34. CrossRef Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat, Frank S. Hwang
Expert Review of Ophthalmology.2017; 12(4): 269. CrossRef New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society
Kazuo Tsubota, Norihiko Yokoi, Jun Shimazaki, Hitoshi Watanabe, Murat Dogru, Masakazu Yamada, Shigeru Kinoshita, Hyo-Myung Kim, Hung-Won Tchah, Joon Young Hyon, Kyung-Chul Yoon, Kyoung Yul Seo, Xuguang Sun, Wei Chen, Lingyi Liang, Mingwu Li, Zuguo Liu, Zu
The Ocular Surface.2017; 15(1): 65. CrossRef Comparisons for Evaluation of Efficacy and Safety of Cyclosporin A 0.05% Ophthalmic Emulsion Treatment Groups
Soonwon Yang, Yong-Soo Byun, Chang Rae Rho, Su Young Kim, Yang Kyung Cho, Eun Chul Kim, Sung Kun Chung, Choun-Ki Joo
Journal of the Korean Ophthalmological Society.2016; 57(12): 1849. CrossRef Customized Liquid Ocular Prosthesis for Anophthalmic Patients suffering from Dry Eye: A Clinical Research
Rubina Gupta, Arjun Bharat, Sushil Nijhawan
International Journal of Prosthodontics and Restorative Dentistry.2016; 6(3): 57. CrossRef Therapeutic Strategies to Treat Dry Eye in an Aging Population
Nisreen S. Ezuddin, Karam A. Alawa, Anat Galor
Drugs & Aging.2015; 32(7): 505. CrossRef Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence
Philip Ames, Anat Galor
Clinical Investigation.2015; 5(3): 267. CrossRef Our experience of Restasis® use in patients with “dry eye” syndrome occurring against the context of graft versus host reaction after bone marrow allografting
Sergey Yur'yevich Astakhov, Natal'ya Viktorovna Tkachenko, Natalya Viktorovna Chistyakova
Ophthalmology Reports.2015; 8(2): 58. CrossRef Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
Clyde Schultz
Ophthalmology and Eye Diseases.2014; 6: OED.S16067. CrossRef Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study
J W Han, J S Yoon, S Y Jang
Eye.2014; 28(10): 1212. CrossRef Effect of Cyclosporin A on Tear Film and Corneal Aberration after Cataract Surgery
Jei Hun Jeon, Hong Seok Kim, Ji Won Jung, Sang Chul Yoon, Kyoung Yul Seo, Hyung Keun Lee, Eung Kweon Kim, Tae Im Kim
Journal of the Korean Ophthalmological Society.2014; 55(7): 978. CrossRef The experience of “Hyloparin” use in clinical practice
Natalya Viktorovna Tkachenko, Sergey Yuryevich Astakhov
Ophthalmology Reports.2014; 7(4): 53. CrossRef Effects of Cyclosporine 0.05% Ophthalmic Emulsion to Improve Reduction of Tear Production after Cataract Surgery
Ae Ri Yoo, Hyung Bin Hwang, Hyun Kyung Kim, Sung Kun Chung
Journal of the Korean Ophthalmological Society.2013; 54(7): 1013. CrossRef
|